4CPS-123 Role of docetaxel in combination with cisplatin and capecitabine in advanced gastric cancer

BACKGROUND: Advanced gastric cancer (AGC) does not have a chemotherapy regimen accepted as standard. Docetaxel has demonstrated benefits associated with cisplatin and 5-fluorouracil in a phase III trial but with modest results and high toxicity, and we need to know how it impacts on more fragile pat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Hosp Pharm
Asıl Yazarlar: Torròn, A Martinez, Alvarez-Manceñido, F, Garcia, I Zapico, Palomo, A Rodriguez, Calero, M Alaguero, Carmona-Bayonas, A, Medical, E Martínez de Castro, Azkarate, A, Mangas, M, Lozano-Blázquez, A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Group 2018
Konular:
Section 4: Clinical pharmacy services
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535175/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.214
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller